New

Ask Wove anything about tariffs.

Try Tariff Assistant

Ephedrine Hydrochloride

Ephedrine hydrochloride is the hydrochloride salt of ephedrine, a natural alkaloid derived from Ephedra plants, reproduced by synthesis for pharmaceutical use. It falls under HTS 2939.49.0300 as a derivative salt of ephedra alkaloids, used primarily in bronchodilators and nasal decongestants. This classification covers synthetic reproductions meeting chapter 29 criteria for separate chemically defined organic compounds.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFree+100.0%100%
🇲🇽MexicoFree+100.0%100%
🇨🇦CanadaFree+100.0%100%
🇩🇪GermanyFree+15.0%15%
🇯🇵JapanFree+15.0%15%

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3004.90Lower: 12.5% vs 100%

If formulated into finished dosage forms like tablets or syrups

Medicinal preparations containing ephedrine salts are classified in Chapter 30 based on therapeutic use rather than chemical composition.

2939.41.00.00Same rate: 100%

If containing thebaine as principal alkaloid instead of ephedrine

Chapter note requires classification in the last occurring heading; thebaine-specific subheading takes precedence over 'other' ephedra derivatives.

3824.99Lower: 17.5% vs 100%

If imported as mixtures with >2% impurities or multiple alkaloids

Mixtures not meeting 'separate chemically defined compound' criteria in chapter note (a) fall under prepared chemical mixtures.

Not sure which classification is right?

The Tariff Assistant works through the GRI rules on your specific product to reach the right HTS code — and can price the duty on it in the same conversation.

Import Tips & Compliance

• Obtain DEA registration and import permit as it's a List I chemical under US controlled substances regulations

• Provide certificate of analysis confirming purity >98% and synthetic origin to avoid natural product misclassification

• Ensure proper labeling as 'pharmaceutical intermediate' to prevent reclassification under Chapter 30 drug preparations